Associate Professor, Dermatology, Perelman School of Medicine
Dermatology
Dr. Carmela C. Vittorio, MD
|
|
Give Review
Carmela C. Vittorio works in the field of Dermatology. She went to Perelman School of Medicine at the University of Pennsylvania. She has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". Carmela Vittorio is a published physician. She has 54 papers published. The most current publication "Widespread tinea corporis in an immunocompetent patient resistant to all conventional forms of treatment." Carmela Vittorio is registered with Medicare.
Publications
- Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.
- Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.
- Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total Skin electron beam therapy.
- Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-Cell lymphoma.
- Chronic Acyclovir-Resistant HSV-2 Ulcer in an Immunosuppressed Patient Treated With Topical Cidofovir.
- Reliability and validity of a photographic method for measuring facial Hair density in men.
- Inhibition of Cell-mediated immunity by the histone deacetylase inhibitor vorinostat: Implications for therapy of cutaneous T-Cell lymphoma.
- High Clinical Response Rate of Sezary Syndrome to Immunomodulatory Therapies: Prognostic Markers of Response.
- Psoralen plus ultraviolet A light may be associated with clearing of peripheral blood disease in advanced cutaneous T-Cell lymphoma.
- Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-Cell lymphoma.
- A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome.
- CD8+ epidermotropic cytotoxic T-Cell lymphoma with peripheral blood and central nervous system involvement.
- Total Skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
- High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome.
- Mycosis fungoides and sezary syndrome: an update.
- The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.
- Immunopathogenesis and therapy of cutaneous T Cell lymphoma.
- Low-dose bexarotene and low-dose interferon alfa-2b for adult T-Cell leukemia/lymphoma associated with human T-lymphotropic virus 1.
- Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-Cell lymphoma: clinical synergism and possible immunologic mechan...
- Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV.
- Complete remission in advanced blastic NK-Cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
- Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-Cell lymphoma.
- Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-Cell lymphoma.
- Effect of wax epilation before Hair removal with a long-pulsed alexandrite laser: a pilot study.
- Laser Hair removal.
- Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-Cell lymph...
- Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-Cell lymphomas.
- Treatment of cutaneous T-Cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.
- Denileukin diftitox for the treatment of panniculitic lymphoma.
- Cytokines and other biologic agents as immunotherapeutics for cutaneous T-Cell lymphoma.
- The risk of malignancy associated with Psoriasis.
- Regression of multifocal, skin-restricted, CD30-positive large T-Cell lymphoma with interferon alfa and bexarotene therapy.
- Papulosquamous disorders of the elderly.
- Therapeutic advances in biological response modifiers in the treatment of cutaneous T-Cell lymphoma.
- A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice.
- Aggressive digital papillary adenoCarcinoma: a case report and review of the literature.
- Preventive techniques to limit glucocorticoid-induced side effects.
- Rate of body dysmorphic disorder in dermatology patients.
- Lamotrigine overdose presenting as anticonvulsant hypersensitivity syndrome.
- Widespread tinea corporis in an immunocompetent patient resistant to all conventional forms of treatment.
- Treatment of habit-tic deformity with fluoxetine.
- Monitoring for major side effects of systemic Drugs in dermatology.
- Epidemiology of human papillomaviruses.
- Anticonvulsant hypersensitivity syndrome.
- Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis.
- Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study.
- The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.
- Reliability and convergent validity of two outcome instruments for pemphigus.
- A prospective clinical trial of open-label etanercept for the treatment of Hidradenitis suppurativa.
- New biologic agents for the treatment of cutaneous T-Cell lymphoma.
- The use of cytokines, fusion proteins and antibodies to treat cutaneous T-Cell lymphoma.
- Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
- A Randomized, Double-blind, Placebo-Controlled Proof of Concept Trial of Topical Cidofovir, 1% and 3%, for the Prevention of Beard Hair Growth in Men.
Schools
University Of Pennsylvania School Of Medicine
Brown University Ri Hospital
Brown University Roger Williams Hospital
Procedures Preformed
- Adjacent Tissue Transfer
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Mohs Surgery
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
Education
-
Brown University -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Penn Presbyterian Medical Center -
Pennsylvania Hospital -
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1073548673 | |
| NPPES Provider LastName | VITTORIO | |
| NPPES Provider FirstName | CARMELA | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 112.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073548673 |
| Last Name Of The Provider | VITTORIO |
| First Name Of The Provider | CARMELA |
| View All |
Similar Doctors
|
|
Dr. Steven S. Greenbaum, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason M. Schoenfeld, MD |
|
|
Dr. Katrina E. Abuabara, MD |
|
|
Dr. Brian C. Capell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer V. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilya Lim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne M. Angeles, MD |
|
|
Dr. Richard G. Vroman, MD |
|
|
Dr. Douglas E. Kligman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ari Gutman, MD
This Doctor is OpenDoctor Recommended.
|